GLIPIZIDE AND METFORMIN HYDROCHLORIDE (glipizide and metformin hcl) by Charter Medical is clinical pharmacology mechanism of action glipizide and metformin hcl tablets combines glipizide and metformin hydrochloride, 2 antihyperglycemic agents with complementary mechanisms of action, to improve glycemic control in patients with type 2 diabetes. Approved for type 2 diabetes mellitus. First approved in 2010.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY Mechanism of Action Glipizide and Metformin HCl Tablets combines glipizide and metformin hydrochloride, 2 antihyperglycemic agents with complementary mechanisms of action, to improve glycemic control in patients with type 2 diabetes. Glipizide appears to lower blood glucose…
Worked on GLIPIZIDE AND METFORMIN HYDROCHLORIDE at Charter Medical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Sulfonylurea